Syndax Pharmaceuticals, Inc. (SNDX) Free cash flow 2016–2025
Syndax Pharmaceuticals, Inc. (SNDX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$323.2MFY2025 · since FY2016: -$35.4M → -$323.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$323.2M | -17.6% |
| FY2024 | -$274.9M | -71.2% |
| FY2023 | -$160.6M | -20.1% |
| FY2022 | -$133.7M | -560.9% |
| FY2021 | $29.0M | +140.7% |
| FY2020 | -$71.3M | — |
| FY2018 | -$68.7M | -44.8% |
| FY2017 | -$47.5M | -34.0% |
| FY2016 | -$35.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice